EDITORIAL
Published on 25 Oct 2022
Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
doi 10.3389/fonc.2022.1053211
- 1,234 views
- 3 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Therapeutic Drug Monitoring and Clinical Toxicology of Anti-Cancer Drugs
Therapeutic Drug Monitoring and Clinical Toxicology of Anti-Cancer Drugs
29k
Total downloads
97k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 07 Jul 2022
External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients
doi 10.3389/fphar.2022.835037
- 2,529 views
- 5 citations
ORIGINAL RESEARCH
Published on 15 Jun 2022
Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data
doi 10.3389/fphar.2022.912256
- 9,861 views
- 19 citations
ORIGINAL RESEARCH
Published on 12 May 2022
Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients
doi 10.3389/fonc.2022.887026
- 1,517 views
- 4 citations
ORIGINAL RESEARCH
Published on 29 Apr 2022
Inhibition of (Pro)renin Receptor-Mediated Oxidative Stress Alleviates Doxorubicin-Induced Heart Failure
doi 10.3389/fonc.2022.874852
- 1,830 views
- 5 citations
REVIEW
Published on 22 Mar 2022
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
doi 10.3389/fonc.2022.821807
- 3,750 views
- 15 citations
ORIGINAL RESEARCH
Published on 21 Mar 2022
LC–MS/MS Method for Measurement of Thiopurine Nucleotides (TN) in Erythrocytes and Association of TN Concentrations With TPMT Enzyme Activity
doi 10.3389/fphar.2022.836812
- 2,503 views
- 3 citations
REVIEW
Published on 18 Mar 2022
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
doi 10.3389/fphar.2022.854967
- 6,039 views
- 23 citations
ORIGINAL RESEARCH
Published on 08 Mar 2022
A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors
doi 10.3389/fonc.2022.790343
- 1,642 views
- 2 citations
REVIEW
Published on 10 Feb 2022
Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies
doi 10.3389/fonc.2022.804212
- 8,423 views
- 19 citations
ORIGINAL RESEARCH
Published on 28 Jan 2022
An Insight on the Pathways Involved in Crizotinib and Sunitinib Induced Hepatotoxicity in HepG2 Cells and Animal Model
doi 10.3389/fonc.2022.749954
- 1,773 views
- 3 citations
CASE REPORT
Published on 27 Jan 2022
Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia
doi 10.3389/fphar.2021.795884
- 2,145 views
- 9 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 97kTopic views
- 65kArticle views
- 29kArticle downloads